创美药业(02289.HK) 公布截至去年12月底止全年业绩，营业额44.35亿元人民币(下同)，按年升0.7%。纯利5,328.41万元，按年升3.8%；每股盈利0.4934元。派末期息0.45元，上年同期派0.3元。(js/u)
| 公布日期 | 派息事项 | 派息内容 |
|---|---|---|
| 2024/08/28 | 中期业绩 | 无派息 |
| 2024/03/28 | 末期业绩 | 股息：人民币 0.3000 (约相等于 0.329771 港元) |
| 2023/08/27 | 中期业绩 | 无派息 |
| 2023/03/31 | 末期业绩 | 股息：人民币 0.4500 (约相等于 0.498866 港元) |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.